Literature DB >> 31014710

Changes in Retinal Thickness on OCT from Intravitreal Melphalan.

Ramsudha Narala1, Jonathan W Kim2, Paul Lang1, Bao Han A Le1, Hansford C Hendargo3, Dorothy Branco3, Jesse L Berry4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31014710      PMCID: PMC6668990          DOI: 10.1016/j.oret.2018.09.020

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN: 2468-6530


× No keyword cloud information.
  5 in total

1.  Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity.

Authors:  Hassan A Aziz; Jonathan W Kim; Francis L Munier; Jesse L Berry
Journal:  Ocul Oncol Pathol       Date:  2016-09-14

2.  Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

Authors:  Jesse L Berry; Sona Shah; Mercy Bechtold; Emily Zolfaghari; Rima Jubran; Jonathan W Kim
Journal:  Pediatr Blood Cancer       Date:  2017-06-24       Impact factor: 3.167

3.  Choroidal thickness after intraarterial chemotherapy for retinoblastoma.

Authors:  Daniel E Maidana; Marco Pellegrini; Jerry A Shields; Carol L Shields
Journal:  Retina       Date:  2014-10       Impact factor: 4.256

4.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS OF DEEP CAPILLARY PLEXUS MICROISCHEMIA AFTER INTRAVENOUS CHEMOTHERAPY FOR RETINOBLASTOMA.

Authors:  Kareem Sioufi; Emil A T Say; Sandor C Ferenczy; Ann M Leahey; Carol L Shields
Journal:  Retina       Date:  2019-02       Impact factor: 4.256

5.  Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013.

Authors:  Francis L Munier
Journal:  Ophthalmic Genet       Date:  2014-10-16       Impact factor: 1.803

  5 in total
  1 in total

1.  Intravitreal Melphalan for Retinoblastoma: The Impact of Toxicity on Recurrence and Ultimate Globe Salvage.

Authors:  Jesse L Berry; Mary E Kim; Maria Pefkianaki; Mark Reid; Rachana Shah; Rima Jubran; Jonathan W Kim
Journal:  Ocul Oncol Pathol       Date:  2020-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.